Nippon Chemical Industrial Co., Ltd. (4092.T) - Deep Dive Research Report

Tokyo Stock Exchange Prime, ticker 4092. Sector: Basic Materials (Specialty & Inorganic Chemicals). Report date: 2026-06-21.

A note on sourcing and reporting cadence. Nippon Chemical Industrial is a Japanese small-cap that reports on a March fiscal year and files four times a year (Q1 June, H1 September, Q3 December, full-year March). The fiscal year ending 31 March 2026 ("FY2026") was reported on 13 May 2026, with the management briefing deck dated 22 May 2026, so the most recent reporting period is the FY2026 full year - well within 90 days of today. The company does not host English-language earnings calls and does not publish concall transcripts; like most Japanese small-caps of its size it communicates through Japanese-language earnings summaries (決算短信) and quarterly briefing materials (決算説明会資料). Sections 7 and 9 therefore draw on those six most-recent filings rather than verbatim call transcripts, and I flag that explicitly where it matters. Per the report's rules, no revenue or profit currency figures, margins, valuation multiples, or price levels appear below; the one quantitative liberty taken in the narrative is segment revenue mix.

Section 1: What the Company Does

Nippon Chemical Industrial makes industrial and specialty chemicals - the unglamorous powders, salts and high-purity compounds that go inside other companies' products. You will never see its name on a shelf. But if you have used a smartphone, driven a modern car, taken certain medicines, or sat in a building with treated water, you have very likely touched an atom that passed through one of its reactors. The company takes basic elements - chromium, phosphorus, silicon, barium, lithium, cobalt - and turns them into engineered materials with tightly controlled purity, particle size and crystal structure, then sells them to manufacturers who build them into capacitors, batteries, semiconductors, flame retardants, agrochemicals and pharmaceuticals.

The business is genuinely old. It traces to September 1893 (Meiji 26), when Torajiro Tanahashi founded the "Tanahashi Pharmaceutical Works" in Azabu, Tokyo, originally to manufacture potassium iodide. In 1908 the company built a plant at Komatsugawa and began making chromium salts - the foundation of what is still one of its core franchises today. It was incorporated in 1915 as Nippon Seiren (Nippon Smelting Co.), and through a series of mergers in the 1920s and 1930s absorbed phosphorus and pigment/barium operations, taking the modern Nippon Chemical Industrial name. More than 130 years on, the same three elemental franchises - chromium, phosphorus, silica - still anchor the "Chemical Products" segment, while everything the company learned about purifying and crystallising inorganic compounds has been redeployed into electronics and battery materials.

The core value proposition is qualification and consistency, not headline chemistry. Many of the molecules the company sells (barium titanate, lithium cobalt oxide, high-purity phosphates) are made by several producers worldwide. What is hard is making them to the exact, lot-to-lot-stable specification that a multilayer ceramic capacitor (MLCC) maker or a semiconductor fab will design into a product and then refuse to re-test. Once a customer qualifies a Nippon Chemical grade into a high-reliability component, switching to another supplier means re-running an expensive, months-long qualification, so the relationships are sticky and the margins live in the purity, not the raw element.

A concrete example: take its barium titanate powder. Nippon Chemical starts from high-purity barium carbonate (which it also makes) and titanium feedstock, reacts and calcines them into barium titanate, then mills and classifies the powder down to sub-micron and even ~100-nanometre particle grades. An MLCC manufacturer - Murata, TDK, Samsung Electro-Mechanics, Taiyo Yuden - stacks hundreds of these dielectric layers, each only microns thick, between nickel electrodes inside a capacitor smaller than a grain of rice. If the powder's particle size distribution drifts, the dielectric layer fails, and a single failed MLCC can kill a car's electronic control unit. So the customer qualifies one supplier's exact powder grade and stays. That is the business in miniature: a commodity element, refined into a qualified material, locked into a customer's bill of materials.

Section 2: Business Segments

Nippon Chemical reports three primary segments - Chemical Products, Functional Products, and Leasing - with a smaller air-conditioning/clean-air-filter activity that sits alongside them as "other" group operations. The two chemical segments are roughly equal in size and together are essentially the whole company; Leasing and the filter business are small but high-quality contributors.

Chemical Products (~46% of revenue)

This is the heritage business: inorganic bulk and specialty chemicals built on the company's three oldest competencies - chromium, phosphorus and silica - plus barium compounds.

What it does. It manufactures chromium compounds (chromic acid, chromium oxides, chromium salts used in plating, catalysts, pigments, metal surface treatment and as raw materials for specialty alloys), phosphorus products (phosphoric acid, phosphates, polyphosphates, red phosphorus - used in detergents, food additives, water treatment, metal treatment and flame retardants), and silica/silicate products (sodium silicate, precipitated silica, silica sols used in detergents, paper, construction, catalysts and coatings), along with barium compounds.

The core capability. Chromium chemistry in particular is a high-barrier, low-glamour franchise. Hexavalent chromium handling is heavily regulated for worker safety and environment, the process is corrosive and hazardous, and very few producers in the developed world still run it at scale. Nippon Chemical has done it continuously since 1908. That regulatory and process know-how - running a hazardous inorganic process safely and at consistent quality for over a century - is exactly the kind of capability that does not get rebuilt by a new entrant.

Why it exists separately. These are mature, scale-and-cost-driven inorganic businesses with industrial end-markets and cyclical demand, economically distinct from the higher-spec, electronics-facing Functional segment. They are the company's cash and ballast.

Competitive position. In chromium it competes with the handful of remaining global chromium-chemical houses (e.g. Lanxess in Germany, Elementis, and Chinese producers); in phosphates and silicates it competes with domestic peers such as Rasa Industries and global phosphate majors. It wins on domestic supply security, regulatory compliance and quality consistency; it loses on raw-material cost against Chinese commodity volume.

How it fits the group. This is the cash cow and the safety net - mature, capital-light relative to electronics, and the franchise that funds the growth bets in Functional Products.

Functional Products (~47% of revenue)

This is the growth engine, and the reason a materials investor would look at the stock.

What it does. It makes electronic ceramic materials (barium titanate and high-purity barium carbonate for MLCC dielectrics), battery materials (lithium cobalt oxide cathode active material for lithium-ion batteries), high-purity electronic materials and circuit materials (for semiconductors and electronic devices), organic phosphorus compounds / phosphine derivatives (used as ligands and catalysts in fine-chemical and pharmaceutical synthesis), agrochemicals and pharmaceutical intermediates.

The core capability. This segment is where the inorganic-purification heritage becomes a precision business. Making barium titanate to MLCC specification is a particle-engineering problem - controlling crystallinity, dopant chemistry (manganese, vanadium, chromium acceptors) and particle-size distribution at the sub-micron and nano scale. Making lithium cobalt oxide to cathode spec is a controlled-crystallisation problem. Both took years of process development and, more importantly, customer qualification to monetise.

Why it exists separately. Different customers (electronics OEMs and component makers, battery makers, pharma), different economics (higher value-add, spec-driven, qualification-locked), different demand cycle (tied to the electronics and EV cycles rather than industrial chemicals), and a different competitive set. It earns its own segment because it is, in effect, a different company bolted onto the same chemical plants.

Competitive position. In barium titanate it competes with Sakai Chemical (the global volume leader), Fuji Titanium, Kyoritsu, Ferro, and Chinese producers such as Shandong Sinocera and Guangdong Fenghua. In lithium cobalt oxide it competes with cathode majors including Sumitomo Metal Mining, Nichia, and Korean/Chinese producers. It is a specialist, not a volume leader - it wins specific high-reliability grades and Japanese-customer relationships rather than commodity tonnage.

How it fits the group. This is the strategic bet. Management's medium-term plan explicitly centres on expanding barium titanate capacity and pushing electronic-materials sales across Asia. It is also the segment most exposed to cyclicality - the FY2026 profit decline was driven by a downcycle in battery materials, only partly offset by strong electronic ceramic materials demand.

Leasing (small, ~3% of revenue)

The company owns land and buildings - in part legacy industrial real estate - and leases them, notably to hospitals and retail tenants, with associated property management and consulting. It is small but steady, high-margin, and counter-cyclical to the chemical businesses. It exists because the company sits on valuable land from its long history and monetises it rather than letting it sit idle. It is a quiet cash contributor and a hidden-asset story, not a growth driver.

Air-conditioning / clean-air filters (small, "other")

A group activity making chemical filters (for removing acidic/basic gases and molecular contaminants from air) plus the design, construction and sale of air-conditioning equipment. This dovetails with the electronics franchise: chemical air filtration is exactly what semiconductor and electronics cleanrooms need, so the business is a natural adjacency to the company's electronic-materials customer base. Small in revenue, strategically coherent.

Section 3: Products and Business Detail

Chromium products. Chromic anhydride, chromium oxides and chromium salts. Used in hard-chrome and decorative plating, metal surface treatment, catalysts, green pigments, and as feedstock for specialty alloys and refractories. The defining characteristic is regulatory: handling hexavalent chromium requires environmental controls, worker-safety compliance, and waste treatment that very few producers maintain. This is a multi-decade franchise that a new entrant in a developed economy effectively cannot start today.

Phosphorus products. Phosphoric acid, sodium and potassium phosphates, polyphosphates, metaphosphates and red phosphorus. End-uses span detergents and cleaning agents, food and beverage additives, water treatment, metal surface treatment, and flame retardants. Red phosphorus and organic phosphorus chemistry also feed into the flame-retardant and fine-chemical lines.

Silica and silicate products. Sodium silicate (water glass), precipitated silica, and silica sols. Used in detergents, paper, construction materials, tyres/rubber, catalysts, and coatings. A classic broad-industrial inorganic line.

Barium compounds. High-purity barium carbonate and barium hydroxide - both sold as products and used internally as the feedstock for barium titanate.

Electronic ceramic materials (barium titanate). The flagship growth product. Barium titanate is the dielectric heart of Class II MLCCs. Nippon Chemical sells multiple grades down to roughly 100-nanometre particle size (e.g. its "420nm" and finer powders) tuned for high-capacitance, high-reliability capacitors used in 5G infrastructure, IoT devices and - the biggest demand vector - automotive electronics, where a single vehicle now contains thousands of MLCCs and the count keeps rising with electrification and ADAS.

Battery materials (lithium cobalt oxide). Cathode active material (LiCoO2) for lithium-ion secondary batteries, historically used in consumer electronics cells. Demand here is cyclical and is currently exposed to the broader battery-materials downcycle and to the long-run shift toward cobalt-light chemistries in some applications.

High-purity electronic & circuit materials, semiconductor materials. Ultra-pure inorganic compounds used in semiconductor and electronic-device manufacturing - the qualification-locked, high-spec end of the catalogue.

Organic phosphorus compounds / phosphine derivatives. Phosphine-based ligands and reagents used as catalysts and intermediates in pharmaceutical and fine-chemical synthesis - a specialty franchise that leans on the company's phosphorus heritage but sells into high-value pharma/agro chemistry.

Agrochemicals and pharmaceutical intermediates. Custom and catalogue intermediates supplied to crop-protection and drug manufacturers.

Manufacturing footprint. Production is concentrated in Japan: Fukushima Prefecture (Koriyama and Miharu - the historic phosphorus and barium sites), Aichi Prefecture (Taketoyo), and Yamaguchi Prefecture (Shunan). The Koriyama/Miharu cluster is the company's oldest and largest base. Manufacturing is domestic and export-oriented rather than offshored, which is a deliberate quality and supply-security stance for qualification-locked materials, but it does concentrate operational and natural-disaster risk in a few Japanese sites.

Milestones that shaped the business. 1893 founding (potassium iodide); 1908 entry into chromium salts; 1915 incorporation; the 1920s-30s phosphorus and barium mergers that created the modern product map; the post-war pivot of inorganic-purification know-how into electronic ceramic and battery materials, which created the Functional Products segment that now matches Chemical Products in size. The current chapter is the medium-term plan's barium titanate capacity expansion and the Asian sales push.

Section 4: Customers

The customer base is industrial and B2B across two broad buckets that mirror the segments.

Chemical Products customers are detergent and household-products makers, water-treatment and infrastructure operators, metal-platers and surface-treatment shops, pigment and coatings makers, food and pharma formulators, and flame-retardant compounders. The buying decision sits with procurement and technical/quality functions; the criteria are price, supply reliability, regulatory compliance (especially for chromium and phosphates), and consistency. Sales cycles are short and relationships long-standing. This is repeat, semi-commoditised business - predictable volume, modest pricing power.

Functional Products customers are where switching costs bite. Barium titanate goes to MLCC manufacturers (Murata, TDK, Taiyo Yuden, Samsung Electro-Mechanics and the broader component industry, directly or through their material qualification chains). Battery material goes to lithium-ion cell makers. High-purity and circuit materials go to semiconductor and electronic-device makers. Here the buying decision involves the customer's materials-engineering and reliability teams, the criteria are purity, particle/crystal consistency and lot-to-lot stability, and the sales cycle is long because every grade must be qualified into a specific component design. Once qualified, the customer rarely re-opens the decision, because re-qualifying a dielectric or cathode material is expensive and risks field failures. That is the switching cost: not a contract, but a qualification.

Concentration. The company does not publicly break out named-customer concentration, but the electronics-materials franchise inevitably skews toward a relatively small set of large MLCC, battery and semiconductor customers, which is both a quality signal (these customers are demanding) and a risk (loss or downcycle of one is felt).

Contract structure. A mix of ongoing supply relationships with qualified customers (predictable, multi-period) in Functional Products and shorter-cycle/spot industrial business in Chemical Products. Leasing adds genuinely recurring multi-year rental income. The blend means revenue is reasonably sticky but exposed to the electronics/battery demand cycle on the growth side.

Section 5: Competitive Landscape

Nippon Chemical is a mid-tier specialist, not a global volume leader in any single product. It competes franchise-by-franchise rather than as one entity, and its edge is consistent: regulatory/process incumbency in hazardous inorganics, qualification lock-in in electronic materials, and Japanese-customer proximity. Its exposure is equally consistent: Chinese commodity volume and cost on the bulk-inorganic side, and scale leaders like Sakai Chemical in barium titanate.

In barium titanate / MLCC dielectric powder, the volume leader is Sakai Chemical Industry, widely cited at roughly a quarter of the global market; other named players include Fuji Titanium, Kyoritsu, Ferro, and the Chinese producers Shandong Sinocera and Guangdong Fenghua. Nippon Chemical plays as a high-reliability specialist rather than a share leader. In chromium chemicals, the relevant peers are the few remaining global houses (Lanxess, Elementis) plus Chinese producers; Western-world capacity has shrunk, which structurally favours the survivors. In lithium cobalt oxide cathode, it sits against far larger cathode majors such as Sumitomo Metal Mining and Nichia and Korean/Chinese cell-material suppliers. In phosphates and silicates, domestic peers like Rasa Industries and global phosphate majors set the competitive frame.

Barriers to entry vary sharply by franchise. Chromium chemistry has a genuine regulatory-and-incumbency moat - you cannot easily permit and build a new hexavalent-chromium plant in a developed economy. Electronic ceramic and high-purity materials have a qualification moat - the molecule is replicable, but the design-in is not, so incumbency with the customer is the barrier. Bulk phosphates and silicates have weak barriers and compete largely on cost, where Chinese scale is the structural threat. So the company is strong exactly where regulation or qualification protects it, and exposed exactly where it does not.

Market caps are approximate, move daily, and are shown only as a peer-size reference as of June 2026. They are not precise figures and should not be read as valuation.

The structural shift to watch is Chinese capacity in both barium titanate and battery materials, which pressures the commoditising end of the catalogue, set against the long-run automotive-MLCC demand tailwind that benefits the qualified high-reliability specialists - a tug-of-war that defines the Functional segment's competitive future.

Section 6: Industry

Nippon Chemical sits at the intersection of two very different industries: mature industrial inorganic chemicals, and high-growth electronic/battery materials.

Demand drivers. On the inorganic side, demand tracks industrial production, construction, detergents/consumer staples, water infrastructure and metal-finishing - GDP-like, slow-growing, regionally driven. On the functional side, the dominant driver is the electronics and automotive cycle: MLCC demand is propelled by vehicle electrification and ADAS (a modern car uses thousands of MLCCs versus hundreds for a conventional one), 5G infrastructure, IoT and AI server build-outs. The barium titanate franchise rides this. Battery-material demand tracks the lithium-ion cycle, currently in a more cautious phase as consumer-electronics cells mature and cobalt-light chemistries gain share in some applications.

Size and growth. Third-party market research consistently describes the barium-titanate-for-MLCC market as a multi-hundred-million-dollar global market growing at a high-single-digit to low-double-digit CAGR through the early 2030s, driven by automotive and high-frequency electronics (Barium Titanate for MLCC market overviews). MLCC unit demand itself is projected to grow steadily on automotive content gains. The inorganic-chemical lines grow roughly with industrial activity.

Position in the supply chain. Nippon Chemical is an upstream material supplier - it sits one or two steps before the visible product (it sells powder to the capacitor maker, who sells to the electronics OEM, who sells to the carmaker). This is a high-spec, low-visibility, qualification-protected position: hard to dislodge once in, but with limited pricing leverage over much larger downstream customers.

Regulation. Chromium chemistry is governed by stringent environmental and worker-safety regulation (hexavalent chromium is a known carcinogen), which is simultaneously a cost and a moat. Phosphates face environmental scrutiny in water/detergent applications. Electronic and battery materials face customer-driven quality and increasingly ESG/traceability requirements (e.g. cobalt sourcing).

Cyclicality. The inorganic side is moderately cyclical with industrial production; the electronics/battery side is sharply cyclical, as the FY2026 battery-materials downturn demonstrated. The Leasing segment is the counter-cyclical ballast.

Tailwinds: automotive MLCC content growth, electrification, AI/data-centre electronics, Western chromium-capacity attrition favouring survivors. Headwinds: Chinese commodity-chemical and electronic-ceramic overcapacity, the battery-material downcycle and cobalt-chemistry transition, raw-material and energy cost volatility, and a strong-yen risk to export competitiveness.

Section 7: Growth Triggers

Drawn from the six most recent reporting periods (FY2026 full-year briefing 22 May 2026; Q3 FY2026 Feb 2026; H1 FY2026 11 Nov 2025; Q1 FY2026 7 Aug 2025; FY2025 full-year briefing 23 May 2025; Q3 FY2025 Feb 2025) and the medium-term management plan. Because the company does not publish call transcripts, these reflect the briefing decks and earnings summaries rather than spoken Q&A.

• Barium titanate capacity expansion - the central capex item of the medium-term plan, expanding electronic-ceramic-material production capacity to serve automotive/5G/IoT MLCC demand. (Medium-term plan; repeated across FY2025 and FY2026 briefings.)

• Electronic ceramic materials demand strength in automotive, 5G and IoT - cited as the strong-performing line that partly offset the battery-materials weakness in FY2026. (Q3 FY2026, Feb 2026; FY2026 full-year briefing, 22 May 2026 - repeated.)

• Asian sales-network expansion - strengthening the sales structure across Asia to push electronic-materials volume closer to component customers. (Medium-term plan; repeated in FY2026 briefings.)

• Three strategic pillars of the medium-term plan to FY2027 - "business expansion and structural strengthening," "promotion of globalisation," and "creation of new value," with explicit financial targets of roughly ¥3.3bn operating profit and ~6% ROE by FY2027, scaling toward a 2030 ambition of ~¥6bn operating profit and ~8% ROE. (FY2025 and FY2026 full-year briefings.)

Management frames the plan around reaching its FY2027 operating-profit and ROE targets and a 2030 "desired state" of roughly double that operating profit, anchored on barium titanate capacity and Asian expansion.

• Shareholder-return ramp as a structural commitment - a formalised total-payout policy (40% payout or 2% DOE, whichever is higher) underpinning two consecutive years of dividend increases. (H1 FY2026 briefing, 11 Nov 2025; reiterated FY2026 full-year.)

The honest read: the growth-trigger pipeline is concentrated and slow-burning. It is essentially one capacity-expansion story (barium titanate) plus a geographic-expansion story (Asia) plus a capital-return story, repeated consistently. There are no dramatic new-customer or new-plant catalysts announced in the recent filings.

Section 8: Key Risks

Battery-materials downcycle and cobalt-chemistry transition. The FY2026 profit decline was driven specifically by weak battery materials (lithium cobalt oxide), only partly offset by electronic ceramics. The mechanism: LiCoO2 demand is tied to consumer-electronics cells and is under structural pressure as some applications shift to cobalt-light chemistries, and the segment is cyclical. If battery materials stay weak while electronic ceramics also soften, the entire Functional growth engine stalls. This is a high-probability, moderate-to-significant drag that has already partly materialised.

Management's own Q3 FY2026 narrative attributed the profit fall principally to declining battery-material demand, with electronic ceramic materials cited as the offsetting bright spot - the company is telling you where the cyclical soft spot is.

Customer and end-market concentration in electronics. The Functional segment leans on a relatively small set of large MLCC, battery and semiconductor customers. Loss of a qualified position, or a sharp MLCC/semiconductor inventory correction, would hit disproportionately. Qualification lock-in cuts both ways: it protects existing positions but makes winning new share slow.

Chinese commodity competition. In bulk phosphates, silicates and increasingly barium titanate, Chinese overcapacity pressures price. The mechanism is straightforward margin erosion at the commoditising end of the catalogue, where the company has no qualification moat.

Geographic and operational concentration. Manufacturing is concentrated in a few Japanese sites (Fukushima/Koriyama-Miharu, Aichi, Yamaguchi). A natural disaster, regulatory action or major incident at a key site - particularly the hazardous chromium operations - would be material. The chromium franchise's regulatory moat is also a regulatory liability: tightening hexavalent-chromium rules or an environmental incident could impose heavy costs.

Slow, capacity-led growth dependent on one bet. The growth story is heavily weighted to barium titanate capacity coming on and being absorbed by automotive MLCC demand. If that demand disappoints or competitors (Sakai, Chinese producers) add capacity faster, the expansion could land into a softer market.

Currency. As a Japanese exporter of qualified materials, a sharply stronger yen would erode export competitiveness and translated earnings - a moderate, ever-present drag rather than a catastrophic risk.

Section 9: Walk the Talk

The six reference periods: FY2026 full year (briefing 22 May 2026), Q3 FY2026 (Feb 2026), H1 FY2026 (11 Nov 2025), Q1 FY2026 (7 Aug 2025), FY2025 full year (briefing 23 May 2025), and Q3 FY2025 (Feb 2025). The most recent is within 90 days of today. Caveat restated: these are Japanese earnings summaries and briefing decks, not call transcripts, so the "walk the talk" assessment is based on guidance-versus-outcome in the filings rather than spoken commitments.

Starting at FY2025 (reported May 2025), management carried a medium-term plan targeting roughly ¥3.3bn operating profit and ~6% ROE by FY2027, and set FY2026 guidance for modest top-line growth with broadly flat-to-slightly-lower operating profit. Importantly, management did not over-promise a profit surge - the FY2026 plan itself embedded an operating-profit decline, which is unusually candid.

Through the year, the company largely did what its filings telegraphed, but with a meaningful negative surprise on mix. At Q1 (Aug 2025) it raised the full-year forecast and lifted the dividend - a confident move. But by Q3 (Feb 2026), cumulative operating profit had fallen materially year on year, tracking well below the historical seasonal pace toward the full-year target, driven by the battery-materials shortfall. Management nonetheless held the full-year forecast at Q3 rather than cutting it - a decision that put credibility on the line.

The Q3 FY2026 print showed cumulative operating profit down sharply and progress toward the full-year operating-profit plan running below the five-year-average pace, yet the full-year forecast was left unchanged.

The FY2026 full-year result (May 2026), followed by a numerical-data correction filed 12 June 2026, is the test of that held forecast. The recurring pattern across the six periods is: conservative-to-honest guidance (the plan openly built in a profit decline), a confident mid-year raise and dividend hike, then a battery-driven shortfall that pressured the back half. That is closer to "realistic, occasionally caught out by its own cyclical segment" than "serial over-promiser."

Where management has been unambiguously consistent and credible is capital return. The dividend was guided up and delivered up two years running - ¥92 for FY2025 then ¥120 for FY2026 - against an explicit, public payout framework, and buybacks were executed, not just authorised. On capital allocation, management says what it does and does what it says.

Net assessment: a credible, conservative management on strategy and a genuinely shareholder-aligned one on capital return, with one watch-item - the decision to hold the FY2026 forecast through a weak Q3, which is exactly the kind of optimism that can dent credibility if the cyclical battery segment does not recover.

Section 10: Shareholder Friendliness Index

Dividends. The trajectory is clearly upward and policy-driven. Dividend per share over the last three fiscal years ran ¥70 (FY2024) → ¥92 (FY2025) → ¥120 (FY2026), i.e. annual payout rose roughly 1.7x in two years; over a longer lens DPS was ¥85 (FY2022) and ¥70 (FY2023), so the recent ramp is a genuine step-up, not just recovery. This is governed by an explicit policy adopted under the medium-term plan: a total payout ratio of 40% or a DOE (dividend-on-equity) of 2%, whichever is higher, which puts a floor under the dividend even in a weak-earnings year (the DOE floor matters because FY2026 earnings were under cyclical pressure). Sources: company dividend disclosures and IR briefings (IR dividend materials; Diamond ZAi coverage of the FY2026 hike).

Buybacks and dilution. The company actively repurchases shares, not just pays dividends. A buyback program announced 23 October 2025 with an upper limit of 100,000 shares (on a base of roughly 8.7 million shares outstanding, so on the order of ~1% of the company) was executed and reported complete around 6 March 2026 (Kabushiki news; company "treasury stock acquisition completion" disclosure, 6 Mar 2026). Earlier treasury-acquisition status reports filed in January and February 2025 indicate a prior program ran in the FY2025 period as well, so buybacks have been a repeated tool, not a one-off. Two source windows, stated separately: (1) MoatMap's last-~90-day window (since 23 March 2026): zero buybacks recorded - consistent, because the FY2026 program had already completed by early March, before that window opened. (2) Older programs, found via filings and news: the ~100,000-share FY2026 buyback (Oct 2025-Mar 2026) plus an earlier FY2025 program (visible in Jan-Feb 2025 status reports). With modest annual buybacks against a small share count and limited option dilution, the share count has been flat-to-slightly-shrinking over three years rather than growing.

Verdict: Returns Capital - two consecutive dividend increases under an explicit 40%/DOE policy and repeated, executed buybacks make this a shareholder-friendly small-cap, with the main caveat that the cash being returned is rising into a cyclically soft earnings patch.

Section 11: Insider Activities

Source and caveat: this section uses the MoatMap cross-market disclosure feed (market JP), which is the canonical source for recent Japanese 5%-rule (大量保有報告書) filings since the official EDINET portal is gated to automated retrieval. The feed is flagged stale - last scrape 2026-06-19 23:00 UTC (about 41 hours before this report), so a very recent filing could be missing. No director/officer open-market dealing was captured in the window; all three captured filings are large-shareholder (5%-rule) reports by Nomura group entities.

Reading the signal - buys. These are not conviction buys by managers. Both buyers are Nomura group entities (the securities arm explicitly holding shares as dealing-desk trading inventory, and the asset-management arm holding on behalf of funds). The Nomura Securities filings show the classic dealer pattern of crossing the 5% reporting threshold up and then down within two weeks (sold 4 June, bought back 19 June) - that is market-making and inventory flow, not an insider expressing a view on the business. The Nomura Asset Management filing is a passive/active fund position crossing 5%, again a portfolio-flow event, not management putting personal money in. So while the raw tally is "2 buys / 1 sell, net buying," it carries essentially zero directional information about insider conviction.

Reading the signal - sells. The single sell (Nomura Securities, 4 June) is the mirror image of the same dealer-inventory dynamic - reason: ordinary trading-book reduction, fully consistent with the buy-back on 19 June. No reason for concern; no disclosed business-related motive because there is none to disclose.

Net assessment. There is no genuine director- or officer-level open-market insider buying or selling in the captured 12-month window - only a securities house's trading inventory and a fund manager's position oscillating around the 5% line. This is neutral: it tells you Nomura's desk and funds are active in the name (a small float of ~8.7 million shares makes 5% crossings easy to trip), but it carries no insider-conviction read in either direction. Note the stale-feed caveat: any director dealing filed in the last ~41 hours, or any sub-5% officer transaction below the disclosure threshold, would not appear here. EDINET large-shareholder reports are the right primary source and would be the place to confirm if a fresh filing is suspected.

Section 12: Scenarios

Bull case. Automotive electrification and AI/data-centre demand keep MLCC unit counts climbing, and the qualified high-reliability end of the barium-titanate market - exactly where Nippon Chemical plays - grows faster than the commodity middle. The capacity expansion at the heart of the medium-term plan comes on line and gets absorbed, the Asian sales build-out lands volume closer to the big component makers, and electronic ceramic materials carry the Functional segment while the battery-materials downcycle bottoms and stabilises. The chromium franchise quietly benefits from continued Western capacity attrition, holding price. The Leasing and filter businesses keep throwing off steady cash. Management hits the FY2027 operating-profit and ROE targets, the 40%/DOE policy keeps the dividend rising, buybacks continue to shrink an already-small share count, and the market starts to value the company as an automotive-MLCC-materials play rather than a sleepy inorganic chemical house. Hidden real-estate value provides downside protection the whole way.

Base case. The most likely path is the company roughly doing what it has guided: low-single-digit revenue growth, operating profit constrained by the battery-materials soft patch and Chinese price pressure at the commodity end, partly offset by electronic-ceramic strength. The barium titanate expansion proceeds but ramps gradually, and the FY2027 targets are approached rather than smashed. Capital return remains the most reliable feature - the dividend holds its upward, policy-anchored trajectory and modest buybacks continue. It stays a steady, conservatively run, cash-generative specialty-chemical small-cap whose growth engine is real but slow-burning, and whose cyclicality occasionally clips a year (as FY2026 showed). Nothing breaks; nothing dramatically re-rates.

Bear case. The battery-materials weakness proves structural rather than cyclical as cobalt-light chemistries take share, and the lithium-cobalt-oxide line becomes a persistent drag. Simultaneously, Chinese barium-titanate and inorganic capacity floods the market, compressing prices in both the commodity lines and the lower-spec electronics grades, so the barium titanate expansion lands into oversupply and runs below target utilisation. An MLCC/semiconductor inventory correction hits the concentrated Functional customer base. Tighter hexavalent-chromium regulation or an environmental/operational incident at a key Japanese site imposes step-up costs on the chromium cash cow. A stronger yen erodes export competitiveness on top of it all. Earnings disappoint against the held forecasts, the dividend's earnings cover thins even as the DOE floor keeps the payout up, and the medium-term targets quietly slip - the same "held the forecast through a weak quarter" optimism flagged in Section 9 turning into a credibility cost.